Onconova Therapeutics In Focus: Stock Up 14.0% - Tale Of The Tape

Onconova Therapeutics, Inc. ONTX was a big mover last session with its shares rising just over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock is has gained over 22% in the past five trading sessions.

This clinical-stage biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Onconova Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Investors interested in the Med-Drugs industry may consider better-ranked stocks like Aeolus Pharmaceuticals Inc. (AOLS), Ariad Pharmaceuticals Inc. ARIA and Ohr Pharmaceutical, Inc. (OHRP). All the three stocks sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

ONCONOVA THERAP ONTX: Free Stock Analysis Report

AEOLUS PHARMACT (AOLS): Get Free Report

ARIAD PHARMA ARIA: Free Stock Analysis Report

OHR PHARMACEUT (OHRP): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs